DK1511764T3 - Peptider og peptidomimetika, som er egnede til hæmning af aktiviteten af prostaglandin f2alfa-receptor - Google Patents

Peptider og peptidomimetika, som er egnede til hæmning af aktiviteten af prostaglandin f2alfa-receptor

Info

Publication number
DK1511764T3
DK1511764T3 DK03735223.4T DK03735223T DK1511764T3 DK 1511764 T3 DK1511764 T3 DK 1511764T3 DK 03735223 T DK03735223 T DK 03735223T DK 1511764 T3 DK1511764 T3 DK 1511764T3
Authority
DK
Denmark
Prior art keywords
f2alfa
prostaglandin
peptides
receptor
inhibiting
Prior art date
Application number
DK03735223.4T
Other languages
English (en)
Inventor
Krishna G Peri
Eryk Thouin
Sylvain Chemtob
Felix Polyak
William Lubell
Original Assignee
Theratechnologies Inc
Univ Montreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theratechnologies Inc, Univ Montreal filed Critical Theratechnologies Inc
Application granted granted Critical
Publication of DK1511764T3 publication Critical patent/DK1511764T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK03735223.4T 2002-06-11 2003-06-11 Peptider og peptidomimetika, som er egnede til hæmning af aktiviteten af prostaglandin f2alfa-receptor DK1511764T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38742402P 2002-06-11 2002-06-11
PCT/CA2003/000903 WO2003104266A2 (en) 2002-06-11 2003-06-11 PEPTIDES AND PEPTIDOMIMETICS USEFUL FOR INHIBITING THE ACTIVITY OF PROSTAGLANDIN F2α RECEPTOR

Publications (1)

Publication Number Publication Date
DK1511764T3 true DK1511764T3 (da) 2012-12-03

Family

ID=29736313

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03735223.4T DK1511764T3 (da) 2002-06-11 2003-06-11 Peptider og peptidomimetika, som er egnede til hæmning af aktiviteten af prostaglandin f2alfa-receptor

Country Status (9)

Country Link
US (2) US7521530B2 (da)
EP (2) EP1511764B1 (da)
AU (1) AU2003236751B2 (da)
CA (2) CA2487061C (da)
DK (1) DK1511764T3 (da)
ES (1) ES2393462T3 (da)
PT (1) PT1511764E (da)
SI (1) SI1511764T1 (da)
WO (1) WO2003104266A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US7521530B2 (en) * 2002-06-11 2009-04-21 Universite De Montreal Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor
US8618054B2 (en) * 2004-05-05 2013-12-31 Valorisation-Rechereche Société en Commandite Interleukin-1 receptor antagonists, compositions, and methods of treatment
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
WO2010124262A1 (en) * 2009-04-24 2010-10-28 Allostera Pharma Inc. Methods of identification of allosteramers and uses thereof
WO2011014649A1 (en) 2009-07-29 2011-02-03 Duke University Compositions and methods for inhibiting hair growth
US8802818B2 (en) 2011-06-02 2014-08-12 William D. Lubell Prostaglandin-F2 alpha receptor modulators and uses thereof
AU2017205254B2 (en) * 2016-01-04 2021-05-20 Xoma (Us) Lcc Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
BR112018013597A2 (pt) 2016-01-04 2019-01-08 ObsEva S.A. composição farmacêutica, método para tratar ou impedir o trabalho de parto prematuro, método para impedir o trabalho de parto antes do parto cesariana, método para tratar ou impedir a dismenorreia e kit
NL2019957B1 (en) 2017-11-22 2019-05-29 Suprapolix Bv Supramolecular biomedical polymers
US11534428B1 (en) 2018-05-16 2022-12-27 Xoma (Us) Llc Compositions and methods for delaying the incidence of labor

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3691016A (en) 1970-04-17 1972-09-12 Monsanto Co Process for the preparation of insoluble enzymes
CA1023287A (en) * 1972-12-08 1977-12-27 Boehringer Mannheim G.M.B.H. Process for the preparation of carrier-bound proteins
US3961016A (en) * 1974-04-26 1976-06-01 The United States Of America As Represented By The United States Energy Research And Development Administration Method of removing carbon monoxide from gases
US4195128A (en) * 1976-05-03 1980-03-25 Bayer Aktiengesellschaft Polymeric carrier bound ligands
US4330440A (en) * 1977-02-08 1982-05-18 Development Finance Corporation Of New Zealand Activated matrix and method of activation
CA1093991A (en) * 1977-02-17 1981-01-20 Hideo Hirohara Enzyme immobilization with pullulan gel
US4229537A (en) * 1978-02-09 1980-10-21 New York University Preparation of trichloro-s-triazine activated supports for coupling ligands
NO812612L (no) 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
IT1164225B (it) * 1983-05-13 1987-04-08 Anic Spa Analoghi retro-invertiti del pentapeptide potenziante la bradichina bpp5a e metodi per la loro preparazione
AU1570292A (en) * 1991-02-07 1992-09-07 Board Of Trustees Of The University Of Illinois, The Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
US5475085A (en) * 1991-02-07 1995-12-12 Molecumetics, Ltd. Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
AU2669992A (en) 1991-11-05 1993-06-07 G.D. Searle & Co. 10-acyl-dibenz(b,f) (1,4)-oxazepines and their thiazepines analo gues useful as prostaglandin antagonists
AU4855393A (en) * 1992-09-10 1994-03-29 New York University Polypeptides of g-coupled receptor proteins, and compositions and methods thereof
US5869281A (en) 1993-06-25 1999-02-09 Merck Frosst Canada Inc. DNA encoding prostaglandin receptor FP
JPH11514207A (ja) 1995-01-25 1999-12-07 シーオーアール・セラピューティックス・インコーポレーテッド 組換えｃ１４０リセプター、そのアゴニストおよびアンタゴニスト、並びに該リセプターをコードする核酸
US5955575A (en) * 1997-12-22 1999-09-21 Hopital Sainte-Justine Antagonists of G-protein-coupled receptor
JP4431280B2 (ja) 1998-09-17 2010-03-10 オピタル・サント−ジュスティーヌ Ｇタンパク質共役型受容体アゴニストまたはアンタゴニスト
ATE265219T1 (de) * 2000-05-09 2004-05-15 Univ British Columbia Verwendung von cxcr4 antagonisten zur behandlung von krebs und autoimmunkrankheiten
US6740490B2 (en) * 2001-01-29 2004-05-25 Kansas State University Research Foundation Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding
US7521530B2 (en) * 2002-06-11 2009-04-21 Universite De Montreal Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor

Also Published As

Publication number Publication date
CA2487061A1 (en) 2003-12-18
WO2003104266A3 (en) 2004-06-10
EP2289905A1 (en) 2011-03-02
SI1511764T1 (sl) 2013-01-31
US7521530B2 (en) 2009-04-21
EP1511764B1 (en) 2012-08-22
AU2003236751B2 (en) 2011-02-03
US20060211626A1 (en) 2006-09-21
WO2003104266A2 (en) 2003-12-18
AU2011201912A1 (en) 2011-05-19
US9073963B2 (en) 2015-07-07
US20120172318A1 (en) 2012-07-05
AU2003236751A1 (en) 2003-12-22
EP1511764A2 (en) 2005-03-09
PT1511764E (pt) 2012-11-15
ES2393462T3 (es) 2012-12-21
CA2487061C (en) 2012-11-13
CA2790348A1 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
DK1504126T3 (da) Fremgangsmåde til regulering af genekspression
NO20052887D0 (no) Pyridazinonderivater som GSK-3Beta inhibitorer.
NO2015010I1 (no) Everolimus - se vedlegg til søknad
DK1575416T3 (da) Fremgangsmåder til diagnosticering af præeklampsi
DE60325025D1 (de) Modulatoren des vanilloidrezeptors
NL1025148A1 (nl) Benzamideremmers van de P2X7-receptor.
NO20051042L (no) Pyrimidylsulfonamidderivater som kemokinreseptormodulatorer
DK1511764T3 (da) Peptider og peptidomimetika, som er egnede til hæmning af aktiviteten af prostaglandin f2alfa-receptor
DK1563069T3 (da) Sammensætninger og systemer til genregulering
DK1505974T3 (da) Anvendelse af forbindelser, der er effektive som selektive opiatreceptormodulatorer
DK1542977T3 (da) 2,5-dioxoimidazolidin-4-ylacetamider og analoger som inhibitorer af metalloproteinase MMP12
DK1840125T3 (da) Mellemprodukter til fremstilling af dioxan-2-alkylcarbamater
NO20055752D0 (no) N-ureidoalkyl-piperidiner som modulerer forbindelser av kjemokinreseptor-aktivitet
DE50312149D1 (de) Ventilsystem
NO20044373L (no) Azetidinderivater som CCR-3-reseptorantagonister
DE60323572D1 (de) Expansionsventil
DE60327491D1 (de) Entspannungsventil
DE60327728D1 (de) Entspannungsventil
DE60321274D1 (de) Entspannungsventil
DE60317999D1 (de) Entspannungsventil
DE60333884D1 (de) Entspannungsventil
ITMI20020549A0 (it) Modulatore criogenico per gascromatografia
DK1482971T3 (da) Strategi til retroviral immunoterapi
ITMI20020198A0 (it) (per)aloeteri
DK1431447T3 (da) Overtrukket membran til anvendelse især som beskyttelsespresenning